Clinical trial
Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus
NCT01964963
Study timeline
Study start (actual)2011-08-03Date precision: day
Registry last updated2019-11-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Interventions
AlogliptinDRUG · verified · RxNorm: alogliptin
Sponsors & collaborators
Takedalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01964963 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.